The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia - Heath,K.E.; Gudnason,V.; Humphries,S.E.; Seed,M. (Atherosclerosis, 1999)